Prize Reinforcement for Smoking Cessation
3 other identifiers
interventional
84
1 country
1
Brief Summary
Nicotine dependence is prevalent in society, cigarette smoking is associated with several known health risks, and most dependent individuals find it very difficult to stop smoking cigarettes. The present study will test the efficacy of a behavioral smoking cessation treatment, prize-based contingency management, that has not undergone rigorous study with respect to smoking, it but has demonstrated efficacy in reducing use of other substances (e.g. cocaine). If efficacious, prize-based contingency management would add to our repertoire of efficacious smoking cessation treatments.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2007
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2007
CompletedFirst Submitted
Initial submission to the registry
March 17, 2009
CompletedFirst Posted
Study publicly available on registry
March 19, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2011
CompletedJune 28, 2013
June 1, 2013
3.9 years
March 17, 2009
June 27, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Expired Carbon Monoxide
Baseline and treatment phases, 2-mont and 6-month follow up.
Secondary Outcomes (2)
Self-reported smoking.
Baseline, throughout treatment, 2-month and 6-month follow up.
Cotinine levels.
Baseline, throughout treatment, 2-month and 6-month follow up.
Study Arms (3)
Traditional Contingency Management
EXPERIMENTALStandard treatment plus prize based contingency management.
Early Enhanced Contingency Management
EXPERIMENTALPrize based contingency management with enhanced magnitude early in treatment and reduced magnitude later in treatment.
Standard Treatment
ACTIVE COMPARATORCounseling and monitoring of smoking cessation.
Interventions
Brief counseling for smoking cessation followed by continued brief supportive sessions and frequent monitoring of smoking cessation efforts.
Prize based contingency management condition in which participants have the chance to win incentives (prizes) when they provide biological test results (expired carbon monoxide and cotinine) that are negative for recent smoking. Prize draws result in incentives on an intermittent schedule (50% of draws are prizes). Participants are also provided with brief counseling for smoking cessation followed by continued brief supportive sessions and frequent monitoring of smoking cessation efforts.
Prize based contingency management condition in which participants have the chance to win incentives (prizes) when they provide biological test results (expired carbon monoxide and cotinine) that are negative for recent smoking. Prize draws result in incentives on an intermittent schedule (100% of draws are prizes in week 1; 33% are prizes in weeks 2-4). Participants are also provided with brief counseling for smoking cessation followed by continued brief supportive sessions and frequent monitoring of smoking cessation efforts.
Eligibility Criteria
You may qualify if:
- A current Fagerstrom scale score of 6 or greater;
- Age 13 years old or older (Under age 18, parental consent is required);
- Able to read and understand English.
You may not qualify if:
- Have current severe, uncontrolled psychiatric disorders (i.e., acute suicidality or psychosis);
- Have current substance dependence, other than nicotine or caffeine dependence;
- Are in recovery for pathological gambling; or
- Are already participating in other behavioral or medication smoking cessation programs.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Wayne State Universitylead
- National Institute on Drug Abuse (NIDA)collaborator
Study Sites (1)
Wayne State University, Jefferson Avenue Research Clinic
Detroit, Michigan, 48207, United States
Related Publications (1)
Reid HH, Ledgerwood DM. Depressive symptoms affect changes in nicotine withdrawal and smoking urges throughout smoking cessation treatment: Preliminary results. Addict Res Theory. 2016;24(1):48-53. doi: 10.3109/16066359.2015.1060967. Epub 2015 Jun 26.
PMID: 27547173DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David M Ledgerwood, Ph.D.
Wayne State University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
March 17, 2009
First Posted
March 19, 2009
Study Start
August 1, 2007
Primary Completion
July 1, 2011
Study Completion
July 1, 2011
Last Updated
June 28, 2013
Record last verified: 2013-06